SAVE THE DATE: April 2, 2025
Translational and Commercial Applications of
Stem Cell-Derived Technologies
The annual Wisconsin Stem Cell Symposium is coordinated by the University of Wisconsin–Madison Stem Cell & Regenerative Medicine Center and the BTC Institute. It is held at the Biopharmaceutical Technology Center (BTC) on the Promega Corporation Campus in Fitchburg/Madison, WI. Promega Campus Map
This year’s Symposium, entitled Translational and Commercial Applications of Stem Cell-Derived Technologies, will bring together speakers that showcase how stem cell-derived technologies and computational tools are being used to enable diverse translational and commercial biomedical applications. The agenda includes speakers from academia and industry, a panel discussion with local industry representatives, and the traditional poster competition/session.
Highlighted topics:
- Clinical translation of iPSC-derived retinal cell therapies
- Commercialization of CNS cell therapies, research and regulatory tools, and disease models
- Clinical translation of iPSC-derived blastoid models
- iPSC models of cardiac tissue for translational regulatory applications and disease modeling
- Endodermal organoid bioengineering and translation
- Cell therapy development in Biotech
- Machine learning applied to single-cell sequencing in Biomedicine
- Applying AI/Machine Learning in biotechnology research and development